A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection

A thorough QT study with dalbavancin: A novel lipoglycopeptide antibiotic for the treatment of acute bacterial skin and skin-structure infections

(2015) Michael W. Dunne et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Staphylococcus aureus Bacteremia at 5 US Academic Medical Centers, 2008-2011: Significant Geographic Variation in Community-Onset Infections

(2014) M. Z. David et al.   CLINICAL INFECTIOUS DISEASES

Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection

(2014) Helen W. Boucher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic Target

(2012) Marilyn N. Martinez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Increasing Burden of Methicillin-Resistant Staphylococcus aureus Hospitalizations at US Academic Medical Centers, 2003–2008

(2012) Michael Z. David et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Decreased Antibiotic Utilization After Implementation of a Guideline for Inpatient Cellulitis and Cutaneous Abscess

(2011) Timothy C. Jenkins et al.   ARCHIVES OF INTERNAL MEDICINE

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Skin and Soft‐Tissue Infections Requiring Hospitalization at an Academic Medical Center: Opportunities for Antimicrobial Stewardship

(2010) Timothy C. Jenkins et al.   CLINICAL INFECTIOUS DISEASES